Complement Aberrations in Serum from Children with Otitis Due to S. Pneumoniae or H. Influenzae

References

• Abrahamson N., Alper C, Lachmann P., Rosen F., Jandl J. Deficiency of C3 inactivator in man. J Immunol 1971; 107: 19
   PubMed Web of Science ®Google Scholar
• Alper C, Colten H., Rosen F., Rabson A., Macnab G., Gear J. Homozygous deficiency of C3 in a patient with relapsed infections. Lancet 1972; ii: 1179
   Google Scholar
• Augener W., Grey H., Cooper N., Müller-Eberhard H. The reaction of monomeric and aggregated immunglobulins with CI. Immunochemistry 1971; 8: 1011
   PubMedGoogle Scholar
• Berglund K., Laurell A.-B., Nived O., Sjöholm A., Sturfelt G. Complement activation, circulating Clq binding substances and inflammatory activity in rheumatoid arthritis: Relations and changes on suppression on inflammation. J Clin Lab Immuno 1980; 14: 7
   Google Scholar
• Bernstein J., Schenkein H., Genco R., Bartholomew W. Complement activity in middle ear effusions. Clin exp Immunol 1978; 33: 340
   PubMed Web of Science ®Google Scholar
• Fearon D., Austen K. Immunochemistry of the classical and alternative pathways of complement. Immunochemistry: An Advanced Textbook, L. Glynn, M. Steward. Wiley, New York 1978; 365
   Google Scholar
• Fine D. Pneumococcal type-associated variability in the alternate complement pathway activation. Infect Immun 1975; 12: 772
   PubMed Web of Science ®Google Scholar
• Forsgren A., Quie P. Influence of the alternate complement pathway on opsonization of several bacterial species. Infect Immun 1974; 10: 402
   PubMed Web of Science ®Google Scholar
• Gewurz H., Shin H., Mergenhagen S. Interactions of the complement system with endotoxic lipopolysaccharide: Consumption of each of the six terminal complement components. J Exp Med 1968; 128: 1049
   PubMed Web of Science ®Google Scholar
• Giebink G., Verhoef J., Peterson P., Quie P. Opsonic requirements for phagocytosis of Streptococcus pneumoniae type VI, XVIII, XXIII and XXV. Infect Immun 1977; 18: 291
   PubMed Web of Science ®Google Scholar
• Johnson U., Kamme C, Laurell A.-B., Nilsson N.-I. Cl subcomponents in acute pneumococcal otitis media in children. Acta Path Microbiol Scand, Sect C 1977; 85: 10
   PubMedGoogle Scholar
• Johnston R., Jr., Klemperer M., Alper C., Rosen F. The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors. J Exp Med 1969; 129: 1275
   PubMed Web of Science ®Google Scholar
• Kamme C, Ageberg M., Lundgren K. Distribution of diplococcus pneumoniae types in acute otitis media in children and influence of the types on the clinical course in penicillin V therapy. Scand J Infect Dis 1970; 2: 183
   PubMedGoogle Scholar
• Kaplan M., Volanakis J. Interaction of C-reative protein complexes with the complement system. I. Consumption of human complement associated with the reaction of CRP with pneumococcal C-poly-saccharide and with the cholin phosphatides, lecithin and sfingomyelin. J Immunol 1974; 112: 2135
   PubMed Web of Science ®Google Scholar
• Klein J. Microbiology of otitis media. Ann Otol Rhinol Laryngol 1980; 89: 98, Suppl. 68
   Web of Science ®Google Scholar
• Laurell C.-B. Electroimmuno assay. Scand J Clin Lab Invest 1972; 29: 21, Suppl. 124
   Web of Science ®Google Scholar
• Laurell A.-B., Mårtensson U., Sjöholm A. Cl subcomponent complexes in normal and pathological sera studied by crossed immunoelectrophoresis. Acta Path Microbiol Scand, Sect C 1976; 84: 455
   Google Scholar
• Laurell A.-B., Mårtensson U., Sjöholm A. The development of simple tests for Clq, Clr, Cls and C2 and the determination of properdin. Clinical Aspects of the Complement System, W. Opferkuch, K. Rother. Georg Thieme Publishers, Stuttgart 1978a; 12
   Google Scholar
• Laurell A.-B., Mårtensson U., Sjöholm A. Formation of complexes composed of Clr-Cls-Cl inactivator in human serum on activation of Cl. Acta Path Microbiol Scand, Sect C 1978b; 86: 299
   Google Scholar
• Laurell A.-B., Mårtensson U., Sjöholm A. Quantitation of Clr-Cls-Cl inactivator complexes by electroimmunoassay. Acta Path Microbiol Scand, Sect C 1979a; 87: 79
   Google Scholar
• Laurell A.-B., Nilsson N.-I., Prellner K. Immune complexes and complement in serous and mucoid otitis media. Acta Otolaryngol (Stockh) 1979b; 90: 290
   Web of Science ®Google Scholar
• Marcus R., Shin H., Mayer M. An alternate complement pathway: C3-cleaving, not due to C4, C2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum; relation to properdin. Proc Natl Acad Sci USA 1971; 68: 1351
   PubMed Web of Science ®Google Scholar
• Müller-Eberhard H., Götze O. C3 proactivator convertase and its mode of action. J Exp Med 1972; 135: 1003
   PubMed Web of Science ®Google Scholar
• Pillemer L., Schoenberg M., Blum L., Wurz L. Properdin system and immunity. II. Interaction of the properdin system with polysaccharides. Science 1955; 122: 545
   PubMed Web of Science ®Google Scholar
• Prellner K. Complement activation by pneumococci associated with acute otitis media. Acta Path Microbiol Scand, Sect C 1979; 87: 213
   Google Scholar
• Prellner K. Bacteria associated with acute otitis media have high Clq binding capacity. Acta Path Microbiol Scand, Sect C 1980; 88: 187
   PubMedGoogle Scholar
• Prellner K. Complement in pneumococcal infections with varying degrees of seventy. Scand J Inf Dis 1981a, in press
   PubMedGoogle Scholar
• Prellner K. Clq binding and complement activation by cap-sular and cell wall components of S. pneumoniae type XIX. Acta Path Microbiol Scand, Sect C 1981b, in press
   PubMedGoogle Scholar
• Ratnoff O., Naff G. The conversion of Cls toC'l-esterase by plasmin and trypsin. J Exp Med 1967; 125: 337
   PubMed Web of Science ®Google Scholar
• Schutte M., DiCamelli R., Murphy P., Sadove M., Gewurz H. C3 proactivator (C3PA) as an acute phase reactant. Clin exp Immunol 1974; 18: 251
   PubMed Web of Science ®Google Scholar
• Shin H., Smith M., Wood B. Heat labile opsonins to pneumococcus. II. Involvement of C3 and C5. J Exp Med 1969; 130: 1229
   PubMed Web of Science ®Google Scholar
• Siegel J., Osmand A., Wilson M., Gewurz H. Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-L-lysine polymers and other poly cations. J Exp Med 1975; 142: 709
   PubMed Web of Science ®Google Scholar
• Sjoholm A. Complement components in normal serum and plasma quantitated by electroimmunoassay. Scand J Immunol 1975; 4: 25
   PubMed Web of Science ®Google Scholar
• Sjoholm A. Studies on Complement Components and on Complement Activation. Thesis. University of Lund. 1979
   Google Scholar
• Sloyer J., Cate C, Howie V., Ploussard J., Johnston R. The immune response to acute otitis media in children. II. Serum and middle ear fluid antibody in otitis media due to. H. influenzae J Infect Dis 1975; 132: 685
   PubMed Web of Science ®Google Scholar
• Sloyer J., Howie V., Ploussard J., Amman A., Austrian R., Johnston R. Immune response to acute otitis media in children. I. Serotypes isolated and serum and middle ear fluid antibody in pneumo-coccal otitis media. Infect Immun 1974; 7: 589
   Google Scholar
• Sobel A., Bokisch V., Müller-Eberhard H. Clq deviation test for the detection of immune complexes, aggregates of IgG, and bacterial products in human serum. J Exp Med 1975; 142: 139
   PubMed Web of Science ®Google Scholar
• Stephens C, Williams R., Jr., Reed W. Classical and alternative complement pathway activation by pneumococci. Infect Immun 1977; 17: 296
   PubMed Web of Science ®Google Scholar
• Volanakis J., Kaplan M. Specificity of C-reactive protein for choline phosphate residues of pneumo-coccal C-polysaccharide. Proc Soc Exp Biol (N.Y.) 1971; 136: 612
   PubMed Web of Science ®Google Scholar
• Ward H., Enders J. An analysis of the tropic action of normal immune sera based on experiments with the pneumococcus. J Exp Med 1933; 57: 527
   PubMedGoogle Scholar
• Winkelstein J., Tomasz A. Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid. J Immunol 1978; 120: 174
   PubMed Web of Science ®Google Scholar
• Zubler R., Lange G., Lambert P., Miescher P. Detection of immune complexes in untreated sera by a modified 125I-Clq binding test. Effects of treating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus. J Immunol 1976; 116: 232
   PubMed Web of Science ®Google Scholar